Bart J.M. van Vlijmen

2.9k total citations
70 papers, 2.1k citations indexed

About

Bart J.M. van Vlijmen is a scholar working on Hematology, Molecular Biology and Surgery. According to data from OpenAlex, Bart J.M. van Vlijmen has authored 70 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 23 papers in Molecular Biology and 19 papers in Surgery. Recurrent topics in Bart J.M. van Vlijmen's work include Blood Coagulation and Thrombosis Mechanisms (18 papers), Lipoproteins and Cardiovascular Health (10 papers) and Platelet Disorders and Treatments (10 papers). Bart J.M. van Vlijmen is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (18 papers), Lipoproteins and Cardiovascular Health (10 papers) and Platelet Disorders and Treatments (10 papers). Bart J.M. van Vlijmen collaborates with scholars based in Netherlands, United States and France. Bart J.M. van Vlijmen's co-authors include Louis M. Havekes, Niels Bovenschen, Marten H. Hofker, Koen Mertens, Theo J.C. van Berkel, Lianne S.M. Boesten, Mark Kockx, Ko Willems van Dijk, Erik A.L. Biessen and J. Wouter Jukema and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Blood.

In The Last Decade

Bart J.M. van Vlijmen

67 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bart J.M. van Vlijmen Netherlands	26	661	568	515	482	315	70	2.1k
Richard Brandl Germany	24	891 1.3×	532 0.9×	539 1.0×	528 1.1×	342 1.1×	61	2.5k
Takatoshi Koyama Japan	28	504 0.8×	447 0.8×	601 1.2×	347 0.7×	145 0.5×	92	2.0k
Josefin Ahnström United Kingdom	22	804 1.2×	433 0.8×	494 1.0×	211 0.4×	166 0.5×	53	1.8k
Tsukasa Matsubara Japan	30	618 0.9×	420 0.7×	472 0.9×	583 1.2×	141 0.4×	105	2.8k
Gautam Shrikhande United States	24	787 1.2×	395 0.7×	363 0.7×	392 0.8×	255 0.8×	42	1.8k
Giovanni Maria Garbarino Italy	28	855 1.3×	231 0.4×	378 0.7×	843 1.7×	177 0.6×	74	2.7k
Changgeng Ruan China	32	856 1.3×	374 0.7×	1.6k 3.0×	663 1.4×	269 0.9×	202	3.1k
Jian Bo China	18	803 1.2×	840 1.5×	202 0.4×	296 0.6×	325 1.0×	65	2.4k
Iris Müller Germany	20	333 0.5×	618 1.1×	569 1.1×	377 0.8×	103 0.3×	34	2.3k

Countries citing papers authored by Bart J.M. van Vlijmen

Since Specialization

Citations

This map shows the geographic impact of Bart J.M. van Vlijmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart J.M. van Vlijmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart J.M. van Vlijmen more than expected).

Fields of papers citing papers by Bart J.M. van Vlijmen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart J.M. van Vlijmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart J.M. van Vlijmen. The network helps show where Bart J.M. van Vlijmen may publish in the future.

Co-authorship network of co-authors of Bart J.M. van Vlijmen

This figure shows the co-authorship network connecting the top 25 collaborators of Bart J.M. van Vlijmen. A scholar is included among the top collaborators of Bart J.M. van Vlijmen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart J.M. van Vlijmen. Bart J.M. van Vlijmen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ali, Mariam, Hendrikus J. A. van Os, Suzanne C. Cannegieter, et al.. (2025). Coagulation Factors and White Matter Hyperintensities in Middle‐Aged Women With and Without Migraine and Ischemic Stroke. European Journal of Neurology. 32(3). e70063–e70063.

Dirven, Richard, Ruben Bierings, Caterina Casari, et al.. (2025). Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs. Blood Advances. 9(2). 310–320. 6 indexed citations

Dirven, Richard, Elisa Schrader Echeverri, Anja W. M. de Jong, et al.. (2025). Silencing of the von Willebrand factor gene in proatherothrombotic APOE∗3-Leiden.CETP transgenic mice. Research and Practice in Thrombosis and Haemostasis. 9(1). 102699–102699.

Echeverri, Elisa Schrader, Richard Dirven, James E. Dahlman, et al.. (2024). Impact of allele-selective silencing of von Willebrand factor in mice based on a single nucleotide allelic difference in von Willebrand factor. Thrombosis Research. 236. 201–208. 7 indexed citations

Exter, Paul L. den, Suzanne C. Cannegieter, Nienke van Rein, et al.. (2024). Quantitative protein mass spectrometry for multiplex measurement of coagulation and fibrinolytic proteins towards clinical application: What, why and how?. Thrombosis Research. 241. 109090–109090. 1 indexed citations

Echeverri, Elisa Schrader, Richard Dirven, Kalina Paunovska, et al.. (2023). Small interfering RNA–mediated allele-selective silencing of von Willebrand factor in vitro and in vivo. Blood Advances. 7(20). 6108–6119. 14 indexed citations

Eikenboom, Jeroen, et al.. (2021). Atherothrombosis model by silencing of protein C in APOE*3-Leiden.CETP transgenic mice. Journal of Thrombosis and Thrombolysis. 52(3). 715–719. 5 indexed citations

Coenen, Daniëlle M., Sophie Dólleman, Annemarie M. van Oeveren‐Rietdijk, et al.. (2020). SLC44A2 deficient mice have a reduced response in stenosis but not in hypercoagulability driven venous thrombosis. Journal of Thrombosis and Haemostasis. 18(7). 1714–1727. 16 indexed citations

Jong, Annika de, Richard Dirven, Johan Boender, et al.. (2020). Ex vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small-Interfering RNA. Thrombosis and Haemostasis. 120(11). 1569–1579. 22 indexed citations

10.

Heestermans, Marco, Annika de Jong, Pieter H. Reitsma, et al.. (2019). Use of “C9/11 Mismatch” Control siRNA Reveals Sequence-Related Off-Target Effect on Coagulation of an siRNA Targeting Mouse Coagulation Factor XII. Nucleic Acid Therapeutics. 29(4). 218–223. 2 indexed citations

11.

Heestermans, Marco, et al.. (2019). Use of "C9/11 Mismatch" Control Small Interfering RNA Reveals Sequence-Related Off-Target Effect on Coagulation of an Small Interfering RNA Targeting Mouse Coagulation Factor XII. Nucleic Acid Therapeutics. 1–6. 1 indexed citations

12.

Jong, Annika de, et al.. (2018). Correction of a dominant‐negative von Willebrand factor multimerization defect by small interfering RNA‐mediated allele‐specific inhibition of mutant von Willebrand factor. Journal of Thrombosis and Haemostasis. 16(7). 1357–1368. 19 indexed citations

13.

Heestermans, Marco, et al.. (2017). Silencing of Anticoagulant Protein C Evokes Low-Incident but Spontaneous Atherothrombosis in Apolipoprotein E–Deficient Mice—Brief Report. Arteriosclerosis Thrombosis and Vascular Biology. 37(5). 782–785. 7 indexed citations

14.

Tang, Seng Chuan, Rolf W. Sparidans, Tatsuki Fukami, et al.. (2014). P-Glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain and Blood Disposition of the mTOR Inhibitor Everolimus (Afinitor) in Mice. Clinical Cancer Research. 20(12). 3133–3145. 31 indexed citations

15.

Nagai, Nobuo, Marc Hoylaerts, Audrey Cleuren, Bart J.M. van Vlijmen, & H.R. Lijnen. (2008). Obesity promotes injury induced femoral artery thrombosis in mice. Thrombosis Research. 122(4). 549–555. 24 indexed citations

16.

Vlijmen, Bart J.M. van, et al.. (2007). Development of a calibrated automated thrombography based thrombin generation test in mouse plasma. Journal of Thrombosis and Haemostasis. 5(10). 2079–2086. 60 indexed citations

17.

Boesten, Lianne S.M., J. Wouter Jukema, Bart J.M. van Vlijmen, et al.. (2006). Dual PPARα/γ Agonist Tesaglitazar Reduces Atherosclerosis in Insulin-Resistant and Hypercholesterolemic ApoE*3Leiden Mice. Arteriosclerosis Thrombosis and Vascular Biology. 26(11). 2560–2566. 40 indexed citations

18.

Dijk, Ko Willems van, Bart J.M. van Vlijmen, Menno P.J. de Winther, et al.. (1999). Hyperlipidemia of ApoE2(Arg ₁₅₈ -Cys) and ApoE3-Leiden Transgenic Mice Is Modulated Predominantly by LDL Receptor Expression. Arteriosclerosis Thrombosis and Vascular Biology. 19(12). 2945–2951. 10 indexed citations

19.

Havekes, Louis M., et al.. (1997). Use of transgenic mice in lipoprotein metabolism and atherosclerosis research. Prostaglandins Leukotrienes and Essential Fatty Acids. 57(4-5). 463–466. 9 indexed citations

20.

Groot, Pieter H.E., Bart J.M. van Vlijmen, G. Martin Benson, et al.. (1996). Quantitative Assessment of Aortic Atherosclerosis in APOE*3 Leiden Transgenic Mice and Its Relationship to Serum Cholesterol Exposure. Arteriosclerosis Thrombosis and Vascular Biology. 16(8). 926–933. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact